The test allows patients to order their own FDA approved swab for private self-collection. The test determines if HPV ...

Screening for cervical cancer every 15 to 25 years was cost-effective for women vaccinated against HPV between the ages of 12 and 24 years.

For HPV testing for detection of cervical intraepithelial neoplasia grade 2/3 or worse, minipad-collected menstrual blood shows comparable diagnostic accuracy.

National data shows women who experience healthcare discrimination favor at-home HPV testing, raising questions about trust ...

While the method shows promise, some experts say that other self-collection devices are more readily available ...

A study reveals menstrual blood can effectively screen for HPV, matching clinician-collected samples in accuracy, enhancing ...

Menstrual blood HPV testing may offer a non-invasive option for cervical cancer screening with strong diagnostic accuracy. Learn more about the study.

Women vaccinated against the human papillomavirus can safely skip many of the cervical cancer screenings that are typically recommended every three to five years, a new study from Norway suggests.

AI-detected extranodal extension could help predict which patients with oropharyngeal carcinoma would benefit from de-escalated treatment and who could use intensified therapies.A retrospective ...

With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

About 70 per cent of cases are prevented through cervical screening, according to cancer research, and the HPV vaccine is ...